Stephen Bruso is an accomplished investment professional, researcher, and consultant with a passion for science and innovation. Having studied at FTTA, Emory University, and Boston University Questrom School of Business, Stephen has leveraged his comprehensive education to build an impressive track record. Currently serving as an Investment Professional at Morningside Venture Capital 晨兴资本, Stephen has also held positions as a board member for various companies, including Cognito Therapeutics and Kuzani Pharmaceuticals. With experience in biotechnology, pharmaceuticals, and IT, Stephen has a diverse skill set that makes him a valuable asset to any team. He has previously worked for Alexion Pharmaceuticals, IT Retail, Bioinnovation Solutions SA, and Pathogenica, Inc.